Cambridge, Mass.
Author: Michael
Rznomics presented interim clinical data for RZ-0
Innovative Vitality, a Chicago-based medical prac
As BioAge’s NLRP3 inhibitor delivers early bio
Phase II Parkinson’s trial moves closer to bra
Life Time’s nationwide rollout brings lab-grad
New CAR deal aims to sharpen targeting and boost
AstraZeneca reported positive high-level results
Insilico Medicine, a clinical-stage generative ar
Inbrain Neuroelectronics announced the completion